Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2...
Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA
EMILIA trial: Trastuzumab emtansine improves progression-free survival in HER2-positive breast cancer ( Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA )
3 Jun 2012
Increased progression-free survival in advanced lung cancer with afatinib
Dr James Yang - National Taiwan University Hospital Taipei, Taiwan
Increased progression-free survival in advanced lung cancer with afatinib ( Dr James Yang - National Taiwan University Hospital Taipei, Taiwan )
3 Jun 2012
Intermittent hormonal therapy versus continuous therapy for advanced prostate...
Dr Maha Hussain - University of Michigan, Ann Arbor, USA
Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )
3 Jun 2012
Changing the standard treatment for lymphoma with bendamustine
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Changing the standard treatment for lymphoma with bendamustine ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Trastuzumab emtansine improves progression-free survival for HER2-positive...
Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA
Trastuzumab emtansine improves progression-free survival for HER2-positive breast cancer ( Dr Kimberly Blackwell - Duke University Medical Center, Durham, USA )
3 Jun 2012
Continuing bevacizumab with second-line chemotherapy for colorectal cancer
Dr Dirk Arnold - University Cancer Center Hamburg, Germany
Continuing bevacizumab with second-line chemotherapy for colorectal cancer ( Dr Dirk Arnold - University Cancer Center Hamburg, Germany )
3 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Intermittent hormonal therapy less effective than continuous therapy when...
Dr Maha Hussain - University of Michigan, Ann Arbor, USA
Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer ( Dr Maha Hussain - University of Michigan, Ann Arbor, USA )
3 Jun 2012
Lower-income Patients are less likely to participate in clinical trials
Dr Joseph Unger - SWOG Statistical Center, Seattle, USA
Lower-income Patients are less likely to participate in clinical trials ( Dr Joseph Unger - SWOG Statistical Center, Seattle, USA )
3 Jun 2012
Bendamustine regimen more effective for lymphoma than standard CHOP
Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany
Bendamustine regimen more effective for lymphoma than standard CHOP ( Dr Mathias Rummel - Universitaetsklinik, Giessen, Germany )
3 Jun 2012
Early results from new PD-1 targeted immune therapy
Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore...
Early results from new PD-1 targeted immune therapy ( Dr Suzanne Topalian - Johns Hopkins University School of Medicine, Baltimore, USA )
2 Jun 2012
New study asks patients preference on kidney cancer treatment
Dr Bernard Escudier - Institut Gustave Roussy, Paris, France
New study asks patients preference on kidney cancer treatment ( Dr Bernard Escudier - Institut Gustave Roussy, Paris, France )
2 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation